RT Journal Article
SR Electronic
T1 A pathologist's survey on the reporting of sessile serrated adenomas/polyps
JF Journal of Clinical Pathology
JO J Clin Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP 426
OP 430
DO 10.1136/jclinpath-2013-202128
VO 67
IS 5
A1 Runjan Chetty
A1 Adrian C Bateman
A1 Emina Torlakovic
A1 Lai Mun Wang
A1 Pelvender Gill
A1 Adnan Al-Badri
A1 Mark Arends
A1 Leigh Biddlestone
A1 Susan Burroughs
A1 Frank Carey
A1 David Cowlishaw
A1 Stephen Crowther
A1 Philip Da Costa
A1 Mahomed A Dada
A1 Charles d'Adhemar
A1 Kaushik Dasgupta
A1 Chandima de Cates
A1 Vikram Deshpande
A1 Roger M Feakins
A1 Bineeta Foria
A1 Vipul Foria
A1 Clare Fuller
A1 Bryan Green
A1 Joel K Greenson
A1 Paul Griffiths
A1 Sara Hafezi-Bakhtiari
A1 James Henry
A1 Eleanor Jaynes
A1 Michael D Jeffers
A1 Philip Kaye
A1 Robert Landers
A1 Gregory Y Lauwers
A1 Maurice Loughrey
A1 Nicholas Mapstone
A1 Marco Novelli
A1 Robert Odze
A1 David Poller
A1 Corwyn Rowsell
A1 Scott Sanders
A1 Patrick Sarsfield
A1 John B Schofield
A1 Kieran Sheahan
A1 Neil Shepherd
A1 Ali Sherif
A1 James Sington
A1 Shaun Walsh
A1 Namor Williams
A1 Newton Wong
YR 2014
UL http://jcp.bmj.com/content/67/5/426.abstract
AB Aim The purpose of this survey was to ascertain reporting habits of pathologists towards sessile serrated adenomas/polyps (SSA/P). Methods A questionnaire designed to highlight diagnostic criteria, approach and clinical implications of SSA/P was circulated electronically to 45 pathologists in the UK and North America. Results Forty-three of 45 pathologists agreed to participate. The vast majority (88%) had a special interest in gastrointestinal (GI) pathology, had great exposure to GI polyps in general with 40% diagnosing SSA/P at least once a week if not more, abnormal architecture was thought by all participants to be histologically diagnostic, and 11% would make the diagnosis if a single diagnostic histological feature was present in one crypt only, while a further 19% would diagnose SSA/P in one crypt if more than one diagnostic feature was present. The vast majority agreed that deeper sections were useful and 88% did not feel proliferation markers were useful. More than one-third did not know whether, or did not feel that, their clinicians were aware of the implications of SSA/P. Conclusions 98% of pathologists surveyed are aware that SSA/P is a precursor lesion to colorectal cancer, the majority agree on diagnostic criteria, and a significant number feel that there needs to be greater communication and awareness among pathologists and gastroenterologists about SSA/P.